Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Inactivated EV71 Vaccine in Infants
NCT01812135Phase 2Withdrawn
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Sep 2011
- Primary completion
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of inactivated EV71 vaccine in enterovirus 71 infection and HIV-associated central nervous system involvement (HAND) (3 arms), sponsored by Sinovac Biotech Ltd. Primary endpoint: Neutralization antibody geometric mean titer. Planned start Sep 2011; status: withdrawn.
02
Drugs
inactivated EV71 vaccine
03
Conditions
enterovirus 71 infectionHIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT01812135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812135.